{
  "paper_id": "PMC4825315",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825315/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "The normal bone marrow (BM) niche. The BM microenvironment is composed of multiple different cell populations that co-ordinately contribute to the regulation of hematopoiesis. The region near the endosteum is highly vascular and thought to be a site where transplanted hematopoietic stem/progenitor cells (HSPC) localize whereas sinusoids in the central portion of the marrow are thought to be the location of most HSPC under homeostasis. CAR cell: CXCL12-abundant reticular cell.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/2a9ed66942bc/1001376.fig1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/2a9ed66942bc/1001376.fig1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/2a9ed66942bc/1001376.fig1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/2a9ed66942bc/1001376.fig1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f1-1001376",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/2a9ed66942bc/1001376.fig1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC4825315/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/2a9ed66942bc/1001376.fig1.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Bone marrow (BM) anatomy. The normal bone marrow anatomy (here using the example of the femur) is composed of different types of bone, blood vessels and red and yellow marrow. HSPC reside in the red marrow where they differentiate into red blood cells, white blood cells and platelets via different progenitor stages (not shown). Yellow marrow represents largely adipocyte-rich regions with minimal hematopoiesis.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/ce486927b5b7/1001376.fig2.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/ce486927b5b7/1001376.fig2.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/ce486927b5b7/1001376.fig2.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/ce486927b5b7/1001376.fig2.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f2-1001376",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/ce486927b5b7/1001376.fig2.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC4825315/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/ce486927b5b7/1001376.fig2.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.",
      "caption": "Leukemia stem cells. Leukemia stem cells (LSC) in acute myeloid leukemia (AML; red), chronic myelogenous leukemia (CML; dark blue), B-cell acute lymphoblastic leukemia (B-ALL; green), chronic lymphocytic leukemia (CLL; pale blue), myelodysplastic syndrome (MDS; orange) and JAK2 V617F positive myeloproliferative neoplasia (MPN; yellow) interact with their bone marrow microenvironment via specific pathways. Specific details are provided in the text. SDF-1α: stromal-derived factor 1α; BMP: bone morphogenetic protein; BMPR: bone morphogenetic protein receptor; Gas6: growth-arrest-specific-gene 6; VEGF (A): vascular endothelial growth factor (A); SCF: stem cell factor; IL-8: interleukin-8; PlGF: placental growth factor; TPO: thrombopoietin; LIF: leukemia-inhibitory factor; PDGF: platelet-derived growth factor; Ang2: angiopoietin2; TGFβ: transforming growth factor β.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/125e8ce23099/1001376.fig3.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/125e8ce23099/1001376.fig3.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/125e8ce23099/1001376.fig3.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/125e8ce23099/1001376.fig3.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f3-1001376",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/125e8ce23099/1001376.fig3.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC4825315/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/125e8ce23099/1001376.fig3.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Figure 4.",
      "caption": "Leukemia stem cell targeting. Depending on the disease entity certain therapies (red) may specifically target the interaction of leukemic stem cells with their bone marrow niche. As detailed in the text, some of these novel therapies have already entered clinical trials. FAK: focal adhesion kinase. Other abbreviations as in Figure 3.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/eeff3e69145a/1001376.fig4.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/eeff3e69145a/1001376.fig4.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/eeff3e69145a/1001376.fig4.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/eeff3e69145a/1001376.fig4.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f4-1001376",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/eeff3e69145a/1001376.fig4.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC4825315/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f11/4825315/eeff3e69145a/1001376.fig4.jpg"
    }
  },
  "claims": [
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These aspects of leukemia biology will be discussed in the context of fundamental niche concepts, as first detailed by Schofield in 1978.3\nFigure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "CAR cell: CXCL12-abundant reticular cell.The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These include arterioloar and sinusoidal type endothelial cells, osteolineage cells, osteoclasts, osteocytes, adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal stem cells, Cxcl12-abundant reticular cells, macrophages, megakaryoctyes and the extracellular matrix (Figure 1).1 These elements affect HSPC number, location, proliferation, self-renewal, and differentiation, and likely alter similar parameters of the LSC.2 Whether the BMM participates in the emergence of leukemia is unclear, though experimental support for this has emerged in animal studies reviewed below.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The normal bone marrow HSPC niche\nThe anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The anatomy and physiology of the normal HSPC niche is still being elucidated, but it is likely that there is heterogeneity among niches as there is heterogeneity among stem cells (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "An activating antibody to α5β1, for example, led to increased adhesion of leukemia cells to fibronectin and decreased their proliferation.59 Interestingly, interferon α restored β1 integrin-mediated adhesion of CML to stromal cells of undefined phenotype inibiting proliferation of CML cells.60,61 Similarly, β1 integrins may play a role in AML, as increased binding of soluble vascular cell adhesion molecule (VCAM)-1 via the β1 integrin VLA-4 was associated with longer overall survival in patients.62\nUnderstanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Understanding of the pathways by which leukemia cells interact with their BMM (Figure 3) will continue to be of great interest, as these pathways may be targetable and thereby make the LSC more sensitive to chemotherapy and other agents.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.In the vascular niche in AML57 and CML56 preliminary data show that treatment with a small molecule inhibitor of E-selectin, which leads to an increase of HSC quiescence and self-renewal in the normal HSC niche,128 may lead to reduction of LSC.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Other strategies to inhibit the LSC niche are encouraging (Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        },
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Other abbreviations as in Figure 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 4,
    "claims_count": 64,
    "images_downloaded": 4,
    "tables_filtered": 34
  }
}